Nephrotic syndrome without extrarenal manifestations

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:567564
Who is this for?
Show terms as
7Active trials8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Nephrotic syndrome without extrarenal manifestations is a kidney disorder where the tiny filtering units in the kidneys, called glomeruli, become damaged and leak large amounts of protein into the urine. Unlike some forms of nephrotic syndrome that affect other organs, this condition is limited to the kidneys. The name means that the disease does not cause problems outside the kidneys (no 'extrarenal' or 'beyond the kidney' effects). When the kidneys leak protein, the body loses important proteins from the blood. This leads to a buildup of fluid in the body, causing swelling — especially around the eyes, legs, and belly. Low protein levels in the blood also make it harder for the body to fight infections and can raise the risk of blood clots. Common symptoms include puffy eyes in the morning, swollen ankles and feet, foamy or frothy urine, weight gain from fluid, and fatigue. Treatment usually focuses on reducing protein loss, controlling swelling, and protecting the kidneys from further damage. Doctors often use steroid medicines as a first step. Some patients respond well to steroids, while others need additional medications. In cases linked to a specific genetic change, treatment may be tailored to the underlying cause. Regular monitoring by a kidney specialist (nephrologist) is essential to manage this condition and preserve kidney function over time.

Key symptoms:

Swelling around the eyes, especially in the morningSwollen ankles, feet, and legsSwollen belly from fluid buildupFoamy or frothy urineUnexplained weight gain from fluid retentionFatigue and low energyReduced amount of urineLoss of appetitePale, dull skinIncreased risk of infectionsHigh cholesterol levels in the bloodBlood clots in some cases

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

9 events
Mar 2026Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria

Brigham and Women's Hospital — PHASE1

TrialNOT YET RECRUITING
Feb 2026Obinutuzumab in Adult Rituximab-Dependent Nephrotic Syndrome

Mario Negri Institute for Pharmacological Research — PHASE2

TrialNOT YET RECRUITING
Dec 2025A Study to Evaluate the Safety, Tolerability and PK of SK-09

Consun Pharmaceutical Group — PHASE1

TrialRECRUITING
Oct 2025Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis

Travere Therapeutics, Inc. — PHASE4

TrialRECRUITING
Sep 2024Effects of Exogenous Ketosis on Proteinuria and Renal Function

Gødstrup Hospital — NA

TrialRECRUITING
Jan 2023Ketoanalogues for Muscle Mass Loss in Nephrotic Syndrome

Military Institute od Medicine National Research Institute — PHASE3

TrialRECRUITING
Aug 2021Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Travere Therapeutics, Inc. — PHASE2

TrialRECRUITING
Apr 2010Nephrotic Syndrome Study Network

University of Michigan

TrialRECRUITING
Feb 2008Proteinuria in Pre and Post Transplant

University of Miami

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Nephrotic syndrome without extrarenal manifestations.

7 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

7 recruitingView all trials with filters →
Phase 31 trial
Ketoanalogues for Muscle Mass Loss in Nephrotic Syndrome
Phase 3
Actively Recruiting
PI: Anna Matyjek (Military Institute of Medicine National Research I) · Sites: Warsaw, Masovian District · Age: 1899 yrs
Phase 41 trial
Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
Phase 4
Actively Recruiting
PI: Radko Komers, MD, PhD (Travere Therapeutics) · Sites: Birmingham, Alabama; New York, New York +7 more · Age: 1899 yrs
Phase 21 trial
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Phase 2
Actively Recruiting
PI: Radko Komers, MD, PhD (Travere Therapeutics, Inc.) · Sites: Los Angeles, California; Wilmington, Delaware +45 more · Age: 117 yrs
Phase 11 trial
A Study to Evaluate the Safety, Tolerability and PK of SK-09
Phase 1
Actively Recruiting
· Sites: Herston, Queensland · Age: 1855 yrs
N/A1 trial
Effects of Exogenous Ketosis on Proteinuria and Renal Function
N/A
Actively Recruiting
PI: Trine Z Lyksholm, MD (University Clinic in Nephrology and Hypertenion, G) · Sites: Herning, Jutland · Age: 1899 yrs
Other2 trials
Nephrotic Syndrome Study Network
Actively Recruiting
PI: Matthias Kretzler, MD (University of Michigan) · Sites: Los Angeles, California; Palo Alto, California +42 more · Age: 080 yrs
Proteinuria in Pre and Post Transplant
Actively Recruiting
PI: George Burke, M.D. (University of Miami) · Sites: Miami, Florida · Age: 025 yrs

No specialists are currently listed for Nephrotic syndrome without extrarenal manifestations.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Nephrotic syndrome without extrarenal manifestations.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Nephrotic syndrome without extrarenal manifestationsForum →

No community posts yet. Be the first to share your experience with Nephrotic syndrome without extrarenal manifestations.

Start the conversation →

Latest news about Nephrotic syndrome without extrarenal manifestations

No recent news articles for Nephrotic syndrome without extrarenal manifestations.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the most likely cause of my nephrotic syndrome, and should I have genetic testing?,How will we know if my treatment is working, and what are the signs of a relapse?,What are the long-term risks to my kidney function, and how can we slow any damage?,Are there clinical trials or newer treatments I should consider?,What dietary changes do I need to make, and should I see a dietitian?,What vaccinations do I need, and are there any I should avoid while on immunosuppressive treatment?,At what point would a kidney transplant be considered, and how does that process work?

Common questions about Nephrotic syndrome without extrarenal manifestations

What is Nephrotic syndrome without extrarenal manifestations?

Nephrotic syndrome without extrarenal manifestations is a kidney disorder where the tiny filtering units in the kidneys, called glomeruli, become damaged and leak large amounts of protein into the urine. Unlike some forms of nephrotic syndrome that affect other organs, this condition is limited to the kidneys. The name means that the disease does not cause problems outside the kidneys (no 'extrarenal' or 'beyond the kidney' effects). When the kidneys leak protein, the body loses important proteins from the blood. This leads to a buildup of fluid in the body, causing swelling — especially arou

Are there clinical trials for Nephrotic syndrome without extrarenal manifestations?

Yes — 7 recruiting clinical trials are currently listed for Nephrotic syndrome without extrarenal manifestations on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.